Equine veterinary practitioners eligible for $15,000 in grant money
Boehringer Ingelheim calls for infectious disease research proposals; Oct. 15 deadline nears.
Boehringer Ingelheim Vetmedica Inc. is calling on the equine industry for help with infectious disease research. The animal health company is asking equine veterinarians, students, teachers and researchers to submit proposals for a yearlong research study and, in turn, five $15,000 awards are up for grabs.
According to the rules posted on Boehringer Ingelheim’s website, an independent review board will select the winners and proposals must address one or more of the following criteria:
> Proposal must show practical application and the ability to improve the diagnosis, pathogenesis, transmission, control and/or prevention of equine infectious disease.
> Equine infectious disease can be bacterial or viral etiology.
The deadline to submit completed proposals is Tuesday, Oct. 15. For more information on the research topic and instructions on how to submit your entry, visit equinediseaseresearch.com.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
